Arundathy N. Pandite - Jan 25, 2025 Form 4 Insider Report for Shattuck Labs, Inc. (STTK)

Role
Chief Medical Officer
Signature
/s/ Andrew R. Neill, Attorney-in-fact for Arundathy N. Pandite
Stock symbol
STTK
Transactions as of
Jan 25, 2025
Transactions value $
-$3,725
Form type
4
Date filed
1/28/2025, 06:04 PM
Previous filing
Jan 13, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STTK Common Stock Tax liability -$3.72K -3.21K -1.53% $1.16 206K Jan 25, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STTK Common Stock Award $0 +206K $0.00 206K Jan 28, 2025 Common Stock 206K $1.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 206,200 shares of the Issuer's common stock, one quarter of which will vest on January 28, 2026, with the remaining three quarters vesting in equal monthly installments through January 28, 2029, subject to the Reporting Person's continued service to the Issuer.